Angiotensin 2 for Hepatorenal Syndrome

NCT04048707 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Funding issues; the study was never started

Conditions

Hepatorenal Syndrome
Cirrhosis
Kidney Failure, Acute

Interventions

DRUG: Angiotensin II
DRUG: Midodrine
DRUG: Octreotide
DRUG: Albumin solution

Sponsor

University of California, Los Angeles